NEW YORK, March 24, 2021 (GLOBE NEWSWIRE) -- Voltron Therapeutics, Inc. today announced positive data from its second set of preclinical animal testing of its HaloVaxâ„¢ Self-Assembling Vaccine (SAV) ...
NEW YORK, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Voltron Therapeutics, Inc. announced today it has initiated its second set of preclinical animal testing of its HaloVaxâ„¢ Self-Assembling Vaccine (SAV) ...